EMBL Australia

EMBL Australia group leader Max Cryle has provided a new understanding of Glycopeptide antibiotics (GPAs) biosynthesis that allows new GPAs to be made and tested in the laboratory - a vital step in the quest to develop new antibiotics to keep pace with the ever-evolving ‘superbugs’ that threaten global public health.

An opinion article by EMBL Australia Scientific Head Professor James Whisstock (published in The Herald Sun on 13 May 2020) calls for a national approach for funding a diversity and depth of scientific research we hope we might never need.

EMBL Australia group leader Professor Eduardo Eyras has developed a general-purpose tool to study how cells function in a common type of brain tumour, but that could also be applied to other tumours and diseases. The research was published in Nature Communications.

PhD student Ebony Monson received a $2000 EMBL Australia travel grant last year, which helped with her ticket to Europe, new networks, potential collaborations and a whole lot of new ideas for the future direction of her novel research.

EMBL Australia group leader Dr Robert Weatheritt was co-awarded a $470,000 ARC Discovery Project grant to study the biogenesis and function of circular RNAs in the brain. The exciting international collaboration begins later this month.

An international team of researchers, co-led by EMBL Australia group leader Dr Richard Morris, has revealed the mechanisms behind fish schooling – and what they found differs from what scientists had previously thought.

An international consortium of researchers, led by EMBL Australia group leader Professor David Lynn, has painstakingly mapped an intracellular network that could open the door to discovering new targeted treatments for colorectal cancer.

An EMBL Australia group leader has co-developed a powerful 3D-printed microscope, making it widely available so researchers can easily harness this powerful technology.

Six EMBL Australia group leaders have been awarded more than $4.3 million in funding for their innovative research through the National Health and Medical Research Council (NHMRC)’s Ideas Grant scheme.

EMBL Australia group leader Dr Harald Janovjak has been awarded a $600,000 ARC Discovery Projects Grant for research that will expand our ability to manipulate nerve cell function with high specificity and without side effects.